These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1289101)

  • 1. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
    Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
    Steffensen R; Sandøe E
    Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
    Maggioni AP; Maseri A; Fresco C; Franzosi MG; Mauri F; Santoro E; Tognoni G
    N Engl J Med; 1993 Nov; 329(20):1442-8. PubMed ID: 8413454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successive ischemic events to a first acute myocardial infarct treated with fibrinolysis. An analysis of GISSI-2 patients considered reperfused by a clinical criterion. Participants in the GISSI-2 study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Bardelli G; Maggi G; Maggi A; Barlera S
    G Ital Cardiol; 1995 Apr; 25(4):463-72. PubMed ID: 7642053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2).
    Moccetti T; Malacrida R; Pasotti E; Sessa F; Genoni M; Barlera S; Turazza F; Maggioni AP
    Arch Intern Med; 1997 Apr; 157(8):865-9. PubMed ID: 9129546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The evolution of hospital mortality due to acute myocardial infarct in the first 2 GISSI studies. Participants in the GISSI 1 and GISSI 2 studies. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mauri F; De Vita C; Staszewsky L; Piantadosi FR; Bosi S; Mantini L; Matta F; Negrini M; Valente S; Martini L [corrected to Mantini L]
    G Ital Cardiol; 1994 Dec; 24(12):1597-604. PubMed ID: 7883133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis.
    Mauri F; Maggioni AP; Franzosi MG; de Vita C; Santoro E; Santoro L; Giannuzzi P; Tognoni G
    J Am Coll Cardiol; 1994 Sep; 24(3):600-7. PubMed ID: 8077527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
    Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
    Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI).
    Correale E; Maggioni AP; Romano S; Ricciardiello V; Battista R; Salvarola G; Santoro E; Tognoni G
    Am J Cardiol; 1993 Jun; 71(16):1377-81. PubMed ID: 8517380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study.
    Zuanetti G; Mantini L; Hernández-Bernal F; Barlera S; di Gregorio D; Latini R; Maggioni AP
    Eur Heart J; 1998 Jun; 19 Suppl F():F19-26. PubMed ID: 9651731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
    Volpi A; de Vita C; Franzosi MG; Geraci E; Maggioni AP; Mauri F; Negri E; Sontoro E; Tavazzi L; Tognoni G
    J Am Coll Cardiol; 1994 Sep; 24(3):608-15. PubMed ID: 8077528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
    Eur Heart J; 1995 Mar; 16(3):313-6. PubMed ID: 7789372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GISSI Study: further analysis. Italian Group for the Study of Streptokinase in Myocardial Infarction (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico, GISSI).
    Franzosi MG; Mauri F; Pampallona S; Bossi M; Matta F; Farina ML; Tognoni G
    Circulation; 1987 Aug; 76(2 Pt 2):II52-6. PubMed ID: 3301057
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.